Estos planes limitados a una práctica están dirigidos principalmente a los 65 millones de estadounidenses que no tienen cobertura dental, y tienen que pagar de su bolsillo toda su atención.
The plans are designed for people who don’t get dental coverage through their jobs and can’t afford an individual plan. For about $300 to $400 a year, patients receive certain preventive services at no charge and other procedures at a discount.
Antes de la era COVID, sentarse hombro con hombro en un estadio con decenas de miles de espectadores gritando era lo que más esperaban los fans en el otoño. Ahora no parece ser la mejor idea.
Fall and football go hand in hand. But with covid-19 cases, hospitalizations and deaths soaring from the delta variant, is it safe to go to the stadium? KHN asks the experts.
Si bien más de 202 millones de estadounidenses están vacunados al menos en parte contra covid, casi el 30% de las personas mayores de 12 años siguen sin vacunarse. Las encuestas muestran que los más pobres tienen menos probabilidades de recibir una vacuna.
A Seattle patient discovers the hard way that you can still hit a lifetime limit for certain types of care. And health plans can vary a lot from one job to the next, even if the insurer is the same.
Efforts by states and the private health plans that many states pay to cover low-income Americans has been scattershot and hampered by a lack of data.
A 2017 law designed to help lower the cost of hearing aids mandated that federal officials set rules for a new class of devices consumers could buy without needing to see an audiologist. But those regulations are still on hold.
As the nation confronts the delta variant, many consumers are again facing delays getting tested. The problem appears most acute in the South and Midwest, where new infections are growing the fastest.
La pandemia ha sido especialmente cruel para los adultos mayores. Casi el 80% de las muertes ocurrieron entre personas de 65 años y más. Millones estuvieron aislados en residencias y en sus casas por meses.
The success in getting shots to older adults is likely due to states prioritizing that effort when the vaccines became available and motivation among the elderly after the virus killed so many in their age group.
The state says it will look at the levels of disease-fighting antibodies among nursing home residents vaccinated against covid, which could help indicate whether they need a booster shot.
The covid pandemic and President Joe Biden’s agenda — a planned $400 billion infusion of support — have focused national attention on the need to expand home- and community-based long-term care services designed to keep people out of nursing homes. But the need far outpaces the staffing.
Los esfuerzos de Biden, que han sido eclipsados en gran medida por otras iniciativas económicas y de salud, representan un cambio abrupto en contra de todo lo que la administración Trump hizo para reducir el programa.
In a sharp shift from Trump-era policies, President Joe Biden looks at expanding Medicaid eligibility to new mothers, inmates and undocumented immigrants and adding services such as food and housing.
In Texas’ border communities, which are overwhelmingly Hispanic, covid-19 death rates for people under age 65 were double those in the rest of the state and three times the national average. They were also significantly higher than rates in New Mexico border areas.
Eager to control costs, health systems and insurers are trying to address patients’ social needs such as food insecurity, transportation and housing. Yet, after years of testing, there’s slim evidence these efforts pay off.
Las últimas cifras de inscripción al Medicaid muestran que creció de 71,3 millones de miembros en febrero de 2020, cuando la pandemia comenzaba en los Estados Unidos, a 80,5 millones en enero, según un análisis de KFF de datos federales.
More than 80 million Americans with low incomes were receiving health coverage through the federal-state program in January. The program now covers nearly 1 in 4 people nationwide.
Federal officials asked a court to dismiss a suit by drugmakers over the policy enacted by the Trump administration that would allow states to bring in cheaper prescription medications from Canada. The filing said the lawsuit was moot because it’s unclear when or if the FDA would approve any state’s importation plan.